Näytä suppeat kuvailutiedot

dc.contributor.authorLe, S.
dc.contributor.authorZhang, Y.
dc.contributor.authorVoutilainen, A.
dc.contributor.authorTan, X.
dc.contributor.authorLaukkanen, J.
dc.contributor.authorWang, C.
dc.contributor.authorCheng, S.
dc.date.accessioned2022-05-24T06:58:16Z
dc.date.available2022-05-24T06:58:16Z
dc.date.issued2022
dc.identifier.citationLe, S., Zhang, Y., Voutilainen, A., Tan, X., Laukkanen, J., Wang, C., & Cheng, S. (2022). Differences in cardiometabolic risk profiles between Chinese and Finnish older adults with glucose impairment and central obesity. <i>Journal of Endocrinological Investigation</i>, <i>45</i>(7), 1427-1437. <a href="https://doi.org/10.1007/s40618-022-01777-8" target="_blank">https://doi.org/10.1007/s40618-022-01777-8</a>
dc.identifier.otherCONVID_144392429
dc.identifier.urihttps://jyx.jyu.fi/handle/123456789/81238
dc.description.abstractBackground Obesity and ethnicity play important roles in cardiovascular complications in patients with type 2 diabetes mellitus (T2DM). This study aimed to compare cardiometabolic risk profiles between Chinese and Finnish older adults of central obesity with prediabetes or T2DM. Methods Study subjects were 60–74 years old and originated from two population samples. The Finnish subjects came from the Kuopio Ischemic Heart Disease (KIHD) study (n = 1089), and the Chinese subjects came from the Shanghai High-risk Diabetic Screen (SHiDS) study (n = 818). The KIHD and SHiDS studies used similar questionnaires to determine participants’ baseline characteristics regarding the history of medication use and diseases and lifestyle factors. All study subjects participated in glucose tolerance tests and anthropometry assessments, including waist circumference measurements. Results Among study subjects of central obesity with prediabetes (n = 298), fasting and 2-h glucose, and fasting insulin and insulin resistance were significantly higher in Chinese than in Finnish (p < 0.0001–0.016). In addition, triglyceride (TG) level was higher and the low-density lipoprotein cholesterol (LDL) and LDL to high-density lipoprotein cholesterol (HDL) ratio were lower in Chinese than in Finnish (p < 0.0001–0.003). Among subjects of central obesity with T2DM (n = 251), Chinese subjects had significantly less proportions of antihypertensive, glycaemic control medication, and statin users as well as lower level of physical activity (p < 0.0001 for all), while higher blood pressure (p = 0.002 for systolic blood pressure and p < 0.0001 for diastolic blood pressure), TG levels (p < 0.05) and HDL (p = 0.002) than the Finnish counterparts. There were no differences in β-cell function (HOMA-β) between Chinese and Finnish both in prediabetes and T2DM. Conclusions Our results indicated that Chinese and Finnish older adults of central obesity with prediabetes and T2DM had similar β-cell function. However, Chinese individuals with prediabetes are prone to insulin resistance. Meanwhile, lipid metabolism dysfunction is also different between Chinese and Finnish. Chinese older adults of central obesity with prediabetes showed higher TG, but Finnish showed higher LDL and LDL/HDL. Strategic for T2DM prevention and treatment should be ethnically specific.en
dc.format.mimetypeapplication/pdf
dc.language.isoeng
dc.publisherSpringer Science and Business Media LLC; Italian Society of Endocrinology
dc.relation.ispartofseriesJournal of Endocrinological Investigation
dc.rightsCC BY 4.0
dc.subject.otherType 2 diabetes mellitus
dc.subject.otherChinese
dc.subject.otherFinnish
dc.subject.otherethnicity
dc.subject.othercentral obesity
dc.subject.othercardiovascular disease risk
dc.titleDifferences in cardiometabolic risk profiles between Chinese and Finnish older adults with glucose impairment and central obesity
dc.typearticle
dc.identifier.urnURN:NBN:fi:jyu-202205242868
dc.contributor.laitosLiikuntatieteellinen tiedekuntafi
dc.contributor.laitosFaculty of Sport and Health Sciencesen
dc.contributor.oppiaineLiikuntalääketiedefi
dc.contributor.oppiaineSports and Exercise Medicineen
dc.type.urihttp://purl.org/eprint/type/JournalArticle
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1
dc.description.reviewstatuspeerReviewed
dc.format.pagerange1427-1437
dc.relation.issn0391-4097
dc.relation.numberinseries7
dc.relation.volume45
dc.type.versionpublishedVersion
dc.rights.copyright© The Author(s) 2022
dc.rights.accesslevelopenAccessfi
dc.subject.ysosydän- ja verisuonitaudit
dc.subject.ysosuomalaiset
dc.subject.ysolihavuus
dc.subject.ysoriskitekijät
dc.subject.ysokiinalaiset
dc.subject.ysoaikuistyypin diabetes
dc.format.contentfulltext
jyx.subject.urihttp://www.yso.fi/onto/yso/p9886
jyx.subject.urihttp://www.yso.fi/onto/yso/p3180
jyx.subject.urihttp://www.yso.fi/onto/yso/p823
jyx.subject.urihttp://www.yso.fi/onto/yso/p13277
jyx.subject.urihttp://www.yso.fi/onto/yso/p19668
jyx.subject.urihttp://www.yso.fi/onto/yso/p8303
dc.rights.urlhttps://creativecommons.org/licenses/by/4.0/
dc.relation.doi10.1007/s40618-022-01777-8
jyx.fundinginformationOpen Access funding provided by University of Jyväskylä (JYU). This work was partly supported by the National Natural Science Foundation of China (NSFC 81770883, 82070913), the Research Start-up Fund from Shanghai Fourth People's Hospital (sykyqd01801), the Shanghai Science and Technology Development Fund (20ZR1446000), the Shanghai Municipal Science and Technology Major Project (2021SHZDZX0100), and the Fundamental Research Funds for the Central Universities.
dc.type.okmA1


Aineistoon kuuluvat tiedostot

Thumbnail

Aineisto kuuluu seuraaviin kokoelmiin

Näytä suppeat kuvailutiedot

CC BY 4.0
Ellei muuten mainita, aineiston lisenssi on CC BY 4.0